Skip to main content
OpenTrials
Completed

NCT Number: NCT05574413

Impact of Acute Exercise Intensity and Pattern on Cytokine Function

The immune system helps prevent illness, fights off infections, and repairs damaged tissues following an injury. However, when immune cells remain active for prolonged periods of time - a state known as "chronic inflammation" - they can contribute to the development and progression of chronic diseases like heart disease and diabetes. Exercise can reduce the risk of developing many of these diseases and at least part of the health benefits of exercise are due to the ability of exercise to reduce "chronic inflammation". The inflammation-lowering effects of exercise are typically captured by measuring hormone-like molecules released from immune cells called "cytokines" in the blood. In addition to changes in circulating cytokine levels, exercise may also alter how immune cells respond to these cytokines. How exercise intensity (i.e., how hard you are working during exercise) and pattern (i.e., exercising as a long continuous bout or in short intervals) impact the ability of immune cells to respond to cytokines is not well understood. A better understanding of how exercise intensity and pattern of exercise for reducing chronic inflammation may help determine the best types of exercises for improving health and preventing chronic diseases.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UBC Okanagan

Kelowna, British Columbia, V1V1V7, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-35 years of age
  • Body mass index between 18.5-30 kg/m^2
  • Free of cardiometabolic and autoimmune/inflammatory disease

Exclusion criteria

  • Competitive endurance athlete
  • Cigarette smoker
  • Currently taking immunomodulatory/anti-inflammatory medications
  • Currently pregnant

Treatment and study plan

Moderate intensity continuous exercise

Other

Participants will perform an acute bout of continuous cycling at 70% of the power output at lactate threshold until an energy expenditure of 350 kcal is achieved. Blood samples will be obtained immediately before and immediately, 30, and 90 minutes after exercise.

Other names: MICE

High intensity continuous exercise

Other

Participants will perform an acute bout of continuous cycling at 10% of the difference between lactate threshold and VO2peak until an energy expenditure of 350 kcal is achieved. Blood samples will be obtained immediately before and immediately, 30, and 90 minutes after exercise.

Other names: HICE

High Intensity Interval Exercise

Other

Participants will perform an acute bout of interval cycling at at 10% of the difference between lactate threshold and VO2peak until an energy expenditure of 350 kcal is achieved. Blood samples will be obtained immediately before and immediately, 30, and 90 minutes after exercise.

Other names: HIIE

Resting (no exercise) control

Other

Participants will remain in a rested state (i.e., no exercise) for the entire session. Blood samples will be obtained at the same time-points as the exercise sessions.

Other names: CTL

Primary outcomes

  1. IL-10 mediated STAT3 phosphorylation

    Time frame: Change from pre-exercise to immediately and 90-min post-exercise

    Ex vivo leukocyte STAT3 phosphorylation in response to IL-10 treatment

Secondary outcomes

  1. IL-10 mediated TNF-alpha inhibition

    Time frame: Change from pre-exercise to immediately and 90-min post-exercise

    Ex vivo inhibition of TNF-alpha production in response to IL-10 treatment

  2. IL-6 mediated STAT3 phosphorylation

    Time frame: Change from pre-exercise to immediately and 90-min post-exercise

    Ex vivo leukocyte STAT3 phosphorylation in response to IL-6 treatment

  3. IL-6 mediated TNF-alpha inhibition

    Time frame: Change from pre-exercise to immediately and 90-min post-exercise

    Ex vivo inhibition of TNF-alpha production in response to IL-6 treatment

  4. Plasma IL-10

    Time frame: Change from pre-exercise to immediately, 30-, and 90-min post-exercise

    Concentration of IL-10 in plasma samples

  5. Plasma IL-6

    Time frame: Change from pre-exercise to immediately, 30-, and 90-min post-exercise

    Concentration of IL-6 in plasma samples

  6. Plasma TNF-alpha

    Time frame: Change from pre-exercise to immediately, 30-, and 90-min post-exercise

    Concentration of TNF-alpha in plasma samples

  7. Hematology panel

    Time frame: Change from pre-exercise to immediately, 30-, and 90-min post-exercise

    Complete blood count

  8. Extracellular vesicles

    Time frame: Change from pre-exercise to immediately, 30-, and 90-min post-exercise

    Concentration of extracellular vesicles in plasma

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Acronym: AEX

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Oct 10, 2022
Registry last updated
Dec 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.